title: Antilymphoblast globulin in renal transplant patients. No allergic reactions.
abstract: The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects* / Q000032:analysis; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D016030:Kidney Transplantation; D012882:Skin Tests; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000961:Antilymphocyte Serum